Delay to therapy following patient controlled atrial shock...

Details Delay to therapy following patient controlled atrial shock... Delay to therapy following patient controlled atrial shock...

2010-06-30

2011-11-01

Layno, Carl H (Department: 3766)

Surgery: light, thermal, and electrical application

Light, thermal, and electrical application

Electrical therapeutic systems

C607S060000, C607S002000, C607S003000

Reexamination Certificate

active

08050755

ABSTRACT:
An implantable cardiac device detects a patient therapy request originating from external to the implantable device. A shock therapy delay period is timed in response to the detection of the patient therapy request. Atrial shock therapy is provided to the patient after expiration of the shock therapy delay period (if the presence of an ongoing atrial arrhythmia is detected). The patient therapy request may be provided by a patient activator including a magnet for operating a reed switch in the implanted device to provide the request. A patient activator including an input and receiver/transmitter circuitry may be employed to request the immediate providing of atrial shock therapy, and/or to set the duration the shock therapy delay period. By allowing specific delays to therapy after a therapy request, a patient can prepare for the requested therapy and thereby mitigate therapy discomfort.

REFERENCES:
patent: 3952750 (1976-04-01), Mirowski et al.
patent: 4344437 (1982-08-01), Markowitz
patent: 4421114 (1983-12-01), Berkovits et al.
patent: 5311449 (1994-05-01), Adams
patent: 5336245 (1994-08-01), Adams et al.
patent: 5342408 (1994-08-01), deCoriolis et al.
patent: 5464431 (1995-11-01), Adams et al.
patent: 5490862 (1996-02-01), Adams et al.
patent: 5518001 (1996-05-01), Snell
patent: 5662689 (1997-09-01), Elsberry et al.
patent: 5674249 (1997-10-01), De Coriolis et al.
patent: 5755737 (1998-05-01), Prieve et al.
patent: 5775737 (1998-07-01), Morgner et al.
patent: 5836975 (1998-11-01), DeGroot
patent: 5999851 (1999-12-01), White
patent: 6016442 (2000-01-01), Hsu et al.
patent: 6068651 (2000-05-01), Brandell
patent: 6453195 (2002-09-01), Thompson
patent: 6618617 (2003-09-01), Chen et al.
patent: 6718198 (2004-04-01), Conley et al.
patent: 6980857 (2005-12-01), Chen et al.
patent: 7024240 (2006-04-01), Chen et al.
patent: 7706877 (2010-04-01), Chen et al.
patent: 7761152 (2010-07-01), Chen et al.
patent: 2002/0156504 (2002-10-01), Chen et al.
patent: 2004/0034389 (2004-02-01), Chen et al.
patent: 2006/0064132 (2006-03-01), Chen et al.
patent: 2006/0079939 (2006-04-01), Chen et al.
“,Medtronic Jewel AF Model 7250 System Reference Guide, Minneapolis, Minnesota”, (1997), pp. 3-11 through 3-12 and 7-11 through 7-13.
“U.S. Appl. No. 11/273,980, Response filed Mar. 30, 2009 to Non Final Office Action mailed Dec. 30, 2008”, 10 pgs.
“U.S. Appl. No. 09/839,122, Examiner Interview Summary filed Aug. 10, 2005”, 1 pg.
“U.S. Appl. No. 09/839,122, Final Office Action mailed Apr. 6, 2005”, 5 pgs.
“U.S. Appl. No. 09/839,122, Non Final Office Action mailed Mar. 9, 2004”, 4 pgs.
“U.S. Appl. No. 09/839,122, Non Final Office Action mailed Sep. 21, 2004”, 5 pgs.
“U.S. Appl. No. 09/839,122, Notice of Allowance mailed Aug. 2, 2005”, 8 pgs.
“U.S. Appl. No. 09/839,122, Response filed Jun. 6, 2005 to Final Office Action mailed Apr. 6, 2005”, 11 pgs.
“U.S. Appl. No. 09/839,122, Response filed Jun. 9, 2004 to Non Final Office Action mailed Mar. 9, 2004”, 8 pgs.
“U.S. Appl. No. 09/839,122, Response filed Dec. 18, 2003 to Restriction Requirement mailed Sep. 24, 2003”, 7 pgs.
“U.S. Appl. No. 09/839,122, Response filed Dec. 21, 2004 to Non Final Office Action mailed Sep. 21, 2004”, 13 pgs.
“U.S. Appl. No. 09/839,122, Restriction Requirement mailed Sep. 24, 2003”, 5 pgs.
“U.S. Appl. No. 10/643,513, Non Final Office Action mailed Jan. 27, 2005”, 8 pgs.
“U.S. Appl. No. 10/643,513, Non Final Office Action mailed Aug. 26, 2004”, 8 pgs.
“U.S. Appl. No. 10/643,513, Notice of Allowance mailed Jul. 26, 2005”, 7 pgs.
“U.S. Appl. No. 10/643,513, Response filed May 27, 2005 to Non Final Office Action mailed Jan. 27, 2005”, 12 pgs.
“U.S. Appl. No. 10/643,513, Response filed Nov. 24, 2004 to Non Final Office Action mailed Aug. 26, 2004”, 10 pgs.
“U.S. Appl. No. 11/264,525 Response to Restriction Requirement mailed Apr. 20, 2009”, 7 pgs.
“U.S. Appl. No. 11/264,525 Restriction Requirement mailed Mar. 18, 2009”, 9 pgs.
“U.S. Appl. No. 11/264,525, Non-Final Office Action mailed Jul. 27, 2009”, 5 pgs.
“U.S. Appl. No. 11/264,525, Notice of Allowance mailed Dec. 18, 2009”, 4 Pgs.
“U.S. Appl. No. 11/264,525, Response filed Oct. 27, 2009 to Non Final Office Action mailed Jul. 27, 2009”, 12 pgs.
“U.S. Appl. No. 11/273,980, Non-Final Office Action mailed Sep. 23, 2009”, 7 pgs.
“U.S. Appl. No. 11/273,980, Response filed Oct. 7, 2008 to Final Office Action mailed Aug. 11, 2008”, 9 pgs.
“U.S. Appl. No. 11/273,980, Advisory Action mailed Oct. 21, 2008”, 3 pgs.
“U.S. Appl. No. 11/273,980, Advisory Action mailed Jul. 27, 2009”, 3 pgs.
“U.S. Appl. No. 11/273,980, Advisory Action Response filed Aug. 12, 2009”, 1 pg.
“U.S. Appl. No. 11/273,980, Final Office Action mailed May 14, 2009”, 8 pgs.
“U.S. Appl. No. 11/273,980, Final Office Action Mailed Aug. 11, 2008”, 7 pgs.
“U.S. Appl. No. 11/273,980, Non-Final Office Action mailed Dec. 30, 2008”, 7 pgs.
“U.S. Appl. No. 11/273,980, Non-Final Office Action mailedFeb. 12, 2008”, 6 pgs.
“U.S. Appl. No. 11/273,980, Notice of Allowance mailed Mar. 12, 2010”, 6 pgs.
“U.S. Appl. No. 11/273,980, Response filed May 12, 2008 to Non-Final Office Action mailed Feb. 12, 2008”, 10 pgs.
“U.S. Appl. No. 11/273,980, Response filed Jul. 15, 2009 to Final Office Action mailed May 14, 2009”, 10 pgs.
“U.S. Appl. No. 11/273,980, Response filed Nov. 12, 2007 to Restriction Requirement mailed Oct. 10, 2007 ”, 7 pgs.
“U.S. Appl. No. 11/273,980, Response filed Dec. 17, 2009 to Non Final Office Action mailed Sep. 23, 2009”, 10 pgs.
“U.S. Appl. No. 11/273,980, Restriction Requirement mailed Oct. 10, 2007”, 6 pgs.

Affiliated with

Also associated with

Rating

Delay to therapy following patient controlled atrial shock... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Delay to therapy following patient controlled atrial shock..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delay to therapy following patient controlled atrial shock... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4278826